Merck, Bristol Myers Squibb, the U.S. Chamber of Commerce and PhRMA filed separate lawsuits against the provision last month.

Johnson & Johnson sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act.

  • Ensign_Crab@lemmy.worldEnglish
    17·
    1 year ago

    We need to shorten the term for patents and make patent extension more difficult for this reason alone.